Description

Technical Parameters

Triptorelin 2mg/bottle Core Introduction

Research -grade lyophilized powder | Gonadotropin-releasing hormone analog (GnRH Agonist) decapeptide

Amino acid sequence : Pyroglutamic acid-histidine-tryptophan-serine-tyrosine-D-tryptophan-leucine-arginine-proline-glycine amide

Molecular weight : 1,311.5 Da

Purity : ≥97% (HPLC)

Specifications : 2mg/bottle (approximately 200mcg/time, 10 doses)

Appearance : White freeze-dried powder

Solvent : 1mL bacteriostatic water

Core Effects

Triptorelin is a potent gonadotropin-releasing hormone analog (GnRH agonist) . Due to its unique biphasic regulation and long-lasting inhibitory effects , it is widely used in the treatment of prostate cancer, precocious puberty, and reproductive endocrinology research .

✅ Bi-phase regulation characteristics :

Short-term agonist effect : Initial use stimulates the pituitary gland to secrete LH and FSH

Long-term suppressive effects : Continuous use leads to pituitary desensitization and suppression of gonadal function

✅ Powerful gonad suppression :

Lowering testosterone to castrate levels (<50 ng/dL) for prostate cancer treatment

Inhibit estrogen production for the treatment of estrogen-dependent diseases

✅ Advantages of long-acting dosage form :

Microsphere sustained-release technology , the effect of a single injection can last for 1-3 months

Stable blood drug concentration , avoiding frequent dosing

✅ Advantages of use :

The therapeutic effect is significant and the hormone suppression effect is achieved quickly

Long dosing intervals improve patient compliance

Usage Protocol

1. Recombination method :

Use 1mL of bacteriostatic water to slowly inject into the wall of the freeze-dried powder bottle

Gently swirl until completely dissolved; avoid vigorous shaking or vortexing

Storage after reconstitution : Refrigerate at 2-8°C and use within 24 hours

2. Injection method :

Injection route : Subcutaneous injection or deep intramuscular injection

Injection dose :

Initial stimulation phase : 100mcg once daily for 7 consecutive days

Maintenance period : 100mcg/time, 3 times a week

Sustained-release dosage form : 3.75 mg/time, once a month deep intramuscular injection

Injection site :

Abdominal subcutaneous : Stable absorption, mild pain

Deep in the gluteus maximus : a dedicated injection site for sustained-release formulations

3. Treatment period :

Prostate cancer treatment : Long-term use until disease progression

Treatment of precocious puberty : Use until normal puberty age

Research use : Use period determined by experimental design

Storage Guidelines

1. Unrestored :

Temperature : -20°C for long-term storage, 2-8°C for short-term storage

Humidity : Relative humidity ≤ 30%, desiccant protection

Light : Store away from light, in brown glass bottle or wrapped in aluminum foil

Expiration date : 24 months at -20°C, 12 months at 2-8°C

2. Storage after reconstitution :

Use Immediately : For best results, use immediately after reconstitution

Store in refrigerator : 2-8°C for no more than 24 hours

Avoid freezing : reconstituted solutions should not be repeatedly frozen and thawed

3. Transport Conditions :

Ultra- low temperature transport : dry ice transport (-78°C)

Shockproof packaging : prevents severe vibrations from affecting the peptide structure

Fast delivery : Delivery within 48 hours to ensure activity

Why choose triptorelin ?

One of the most potent GnRH agonists , with reliable gonadal suppression effect

Unique biphasic mechanism of action to meet different treatment needs

Long-acting formulations are available , greatly improving treatment convenience

Quality Assurance :

GMP -compliant production , each batch HPLC purity tested (≥97% )

Third-party laboratory report (COA) is included with the product

Sterile freeze-drying process to ensure no endotoxin

Worldwide Shipping :

Medical vial packaging , rubber stopper seal

Dry ice transportation to ensure peptide activity

Private delivery , no logo on the outer packaging

Conclusion

Triptorelin is an advanced tool for reproductive endocrine research and the treatment of gonadal disorders . It is particularly suitable for the treatment of prostate cancer, precocious puberty, and reproductive physiology research . The recommended dose is 100mcg/time, with frequency adjusted based on intended use .

Need a specific research plan ?

We provide professional technical guidance to help you conduct your research safely and efficiently!

Need anything, please contact us